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Purpose: A study was made of the binding properties of trifoliate yam starch, obtained from 
Dioscorea dumetorum (Pax), in chloroquine phosphate tablet formulations in comparison with 
official corn starch.  
Method: Compressional properties were analyzed using density measurements and 
compression equations of Heckel and Kawakita. The mechanical properties of the tablets 
were assessed using the crushing strength and friability of the tablets, while drug release 
properties of the tablets were assessed using disintegration and dissolution times.  
Results: Tablet formulations containing trifoliate yam starch exhibited faster onset and higher 
amount of plastic deformation during compression than those containing corn starch. The 
crushing strength, disintegration and dissolution times of the tablets increased with binder 
concentration while friability values decreased. Trifoliate yam starch produced tablets with 
stronger mechanical properties and longer disintegration and dissolution times than those 
containing corn starch.  
Conclusion: Trifoliate yam starch would be a better alternative to corn starch in producing 
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INTRODUCTION 
A survey of the literature shows that the 
usefulness of starches from various botanical 
sources as pharmaceutical excipients has 
formed a subject of interesting study for close to 
four decades 1-5. Starches are widely available 
and have been very useful in tablet production 
due to their inertness, cheapness and utilization 
as fillers, binders, disintegrants and glidants 6,7.  
Many starches obtained from different 
food crops have shown enough potential as 
excipients in tablet formulations to stimulate 
further research and development efforts. In this 
regard, a lot of efforts have been expended to 
develop locally produced starches as binders 
and disintegrants8. Nasipuri evaluated the use of 
Dioscorea rotundata as a binder and disintegrant 
in tablet formulation1 and Itiola also investigated 
the compressional properties of this particular 
starch 9. However, little work has been done to 
evaluate the effects of trifoliate yam starch 
obtained from Dioscorea dumetorum (Pax) on 
the compressional, mechanical and release 
properties of tablet formulations. 
The Heckel equation is widely used for relating 
the relative density, D, of a powder bed during 
compression to the applied pressure, P 10, 11. It is 
written as: 





1ln   [1] 
where K and A are constants. 
 
The Heckel equation is a sensitive tool 
to study the compressibility of materials. It 
describes the relationship of the compact density 
to the applied pressure. The slope of the straight 
line portion, K, is the reciprocal of the mean yield 
pressure, Py, of the material.  The intercept of 
the extrapolated linear portion, A, is a function of 
the original compact volume. 
 From the value of A, the relative Density 
(DA) can be calculated using the following 
equation. 
 DA = 1-e-A              [2] 
The relative density of the powder bed at 
the point when the applied pressure equals zero, 
DO, is used to describe the initial rearrangement 
phase of densification as a result of die filling 
and this is obtained from the ratio of the loose 
density to the particle density.  The relative 
Density, DB, describes the phase of 
rearrangement of particles during the initial 
stages of compression.  The extent of 
rearrangement phase depends on the theoretical 
point of densification at which deformation of 
particles begins. 
Thus, DB = DA - D0          [3] 
The Kawakita equation13  is used to 
study of powder compression using the degree 
of volume reduction (C) and is written as: 
)1()( bPabPVoVpVoC +=−=            [4] 
 The equation in practice can be 
rearranged as: 
( ) ( )abaPCP 1+=                 [5] 
in which Vo is the powder’s initial bulk 
volume and Vp is the bulk volume after 
compression. The constant, ‘a’ is the material’s 
minimum porosity before compression while the 
constant ‘b’ relates to the material’s plasticity. 
The reciprocal of b defines a pressure term Pk, 
which is the pressure required to reduce the 
powder bed by 50% 14, 15. 
Thus, the present study was designed to 
evaluate the effects of trifoliate yam starch as a 
binder in a chloroquine phosphate tablet 
formulation in comparison to official corn starch 
BP grade. 
Chloroquine phosphate was chosen for 
the work because of its poor tableting properties 
and hence requires a binder among other 
excipients to form satisfactory tablets. 
 
MATERIALS AND METHODS 
 
Materials   
 The materials used were chloroquine 
phosphate powder (product of People’s Republic 
of China, made to the specification of BP 1988, 
and supplied by Bentos Pharmaceutical 
Products Ltd., Nigeria), corn starch BP (Lot 
69833 supplied by Bentos Pharmaceutical 
Products Ltd., Nigeria), Lactose B. P (DVM 
Veghel, Holland) and Trifoliate (Wild) yam starch 
obtained from the tubers of Dioscorea 
dumetorum (Pax). The experimental starch was 
prepared in a University of Ibadan laboratory. 
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The description of the preparation and 
purification of the starches have been given 
elsewhere 12. The particle density of granules 
was determined by the pycnometer method 
using xylene as the displacement fluid 
 
Preparation of granules  
 250g batches of a basic formulation 
comprising of chloroquine (60%w/w), Lactose 
(30% w/w) and corn - starch (10% w/w) were dry 
mixed for about five minutes in a Kenwood 
planetary mixer.  The mixture was then 
moistened with appropriate amount of pastes of 
the binding agent (Wild yam, Dioscorea 
dumetorum starch or and corn starch) to 
produce samples containing 2.5, 5.0, 7.5 and 
10.0%w/w of the binders. 
 Massing was continued for about five 
minutes and the wet masses were granulated by 
passing them manually through a N0 12 mesh 
sieve (1,400µm).  The granules were dried in a 
hot air oven for 24hours at 600C and then 
resieved through a N0 16 mesh sieve (1,000µm), 
before they were stored in air - tight containers. 
 
Determination of pre-compression pressure 
 The bulk density of each formulation at 
zero pressure (loose density) was determined by 
pouring the granules into a 50ml glass 
measuring cylinder with a diameter of 24mm   
through a funnel at an angle of 45o.  
Determinations were made in triplicate. The 
relative density Do of each formulation was 
obtained from the ratio of the loose density to its 
particle density. 
 
Preparation of tablets 
 A Carver hydraulic hand press (Model C, 
Carver Inc, Menomonee Falls, Wisconsin, U. S. 
A), fitted with a pressure gauge reading up to 2.5 
metric tonnes was used. 
 Granules of size fraction 500 - 1,000µm 
were used to prepare 400mg + 10mg tablets 
using a 10.5mm diameter die in combination with 
flat faced upper and lower punches.  Before 
each compression, the punches and die were 
lubricated by brushing with 2% w/v dispersion of 
magnesium stearate in ethanol - ether (1:1). 
After ejection, the tablets were stored over silica 
gel for 24hr before tablet properties were 
determined, to allow for elastic recovery and 
hardening and prevent false low yield values. 
 The weights (w) of the tablets were 
accurately determined at room temperature to 
within + 1mg while the diameter and thickness of 
the tablets were accurately measured to within + 
0.01mm .The relative densities D, of the tablets 
were calculated from the equation: 
stV
wD ρ.=     [6] 
                   
where Vt is the volume of tablet (cm3)  and ρs is 
the particle density of the solid material (g/cm3). 
 
Crushing strength and friability tests 
Ten tablets from each formulation were 
tested for diametrical crushing test using the 
Erweka TBH 28 hardness tester (Apparatebau, 
GMBH, Germany). Measurements were made in 
triplicate on individual tablets and the crushing 
strength results were accepted only if the 
samples split cleanly into two halves. The 
friability of the tablets was also determined using 
the Veego tablet friability apparatus (Veego 
Scientific Devices, Mumbai, India) at a speed of 
25rpm for 4minutes. 
 
Disintegration test 
 The disintegration times of the tablets 
were determined in distilled water at 370 + 0.50C 
using the Apex disintegration testing Apparatus 
(Apex Construction Ltd; Northflect Gravescent 
and Dartford, Kent,U.K). 
 Tablets were placed on the wire mesh 
just above the surface of the water in the tube 
and the apparatus was started simultaneously 
with a stop clock.  The tablets were kept in 
contact with distilled water contained in the tube.  
The time taken for all the tablets to disintegrate 
and go through the wire mesh was recorded.  
Determinations were made in triplicate. 
 
Dissolution test 
 The dissolution rate of the tablets was 
determined in distilled water using the Rotating 
Basket (USP Apparatus I) method. Each tablet 
was placed in a cylindrical basket of stainless 
wire mesh attached to a variable speed drive 
mechanism and suspended in a glass vessel 
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containing 900mls of distilled water which was 
immersed in a water bath set at 370+ 0.50C. 
 The apparatus was set to rotate at 
100rpm and was started simultaneously with a 
stop clock. 5ml samples of the dissolution 
medium was removed at designated intervals 
and replaced with an equal volume of fresh 
sample of dissolution medium. The absorbance 
of the removed samples was measured and the 
total concentration of drug in each sample was 
determined using a UV spectrophotometer (SP6-




 Statistical analysis was done to compare 
the effect of trifoliate yam starch and corn starch 
on tablet properties using the t-test. At 95% 
confidence interval, p value lower or equal to 






RESULTS AND DISCUSSION 
 Fig. 1 shows representative Heckel plots 
for chloroquine phosphate formulations 
containing 5%w/w binder. The mean yield 
pressure, Py, was calculated from the regions of 
the plots showing linearity with correlation 
coefficient of ≥ 0.990 for all formulations 
(generally between 56.62 and 198.16MNm-2). 
The intercept A was determined from the 
extrapolation of the region used for the 
determination of Py. The intercept represented 
the point at which a coherent or intact tablet was 
just formed during compression. The values of 
DA and DB were calculated from Eqn. 2 and 3 
respectively. The values of PY, DO, DA, and DB 
for the formulations are presented in Table 1.  
The values of D0 for the various 
formulations increased with binder 
concentration, implying that the initial packing of 
the formulation as a result of die filling increased 
with increase in binder content. These values 
were found to be higher for formulations 




TABLE 1: Parameters Obtained From Density Measurements and Heckel And Kawakita Plots  
                                                                                                              
   Heckel Plots Kawakita Plots 
Starch  Binder  
conc. (% w/w) 
Do Py 
(MN/m2) 
DA DB Pk 
(MN/m) 
Di 
                         0.0 0.276 95.56 0.863 0.587 3.212 0.424 
Trifoliate yam   2.5 0.346 114.21 0.772 0.426 2.661 0.410 
                         5.0 0.387 111.12 0.802 0.415 2.583 0.403 
                         7.5 0.392 96.91 0.800 0.408 2.449 0.397 
                         10.0 0.357 90.81 0.783 0.401 2.385 0.362 
Corn Starch      2.5 0.284 142.86 0.830 0.546 2.889 0.339 
 5.0                        0.281 125.10 0.823 0.542 2.770 0.321 
 7.5                        0.278 121.41 0.817 0.539 2.685 0.318 
 10.0                      0.261 97.62 0.793 0.532 2.496 0.299 
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 The mean yield pressure Py is inversely 
related to the ability of a material to deform 
plastically when compressed. The values of Py 
decreased with increase in binder concentration, 
with formulations containing trifoliate yam starch 
having lower values compared to corn starch. 
This implies that the onset of plastic deformation 
in the formulations containing trifoliate yam 
starch was faster than those containing corn 
starch. 
 Fig. 2 shows representative Kawakita 
plots for chloroquine phosphate formulations 
containing 5% w/w binders. A linear relationship 
was obtained at all compression pressures 
employed with a correlation coefficient ≥ 0.999 
for all formulations. Values of a and ab were 
obtained from the slope and intercept of the 
plots, respectively. Values of 1-a give the initial 
relative density, DI, of the formulations, while Pk 
values were obtained from the reciprocal of 
values of b. Values of Pk and DI are included in 
Table I. 
 The DI values decreased with 
concentration of starch binder in all formulations, 
with formulations containing trifoliate yam starch 
having lower values than corn starch 
formulations. The DI values are also observed to 
be higher than the corresponding values of loose 
initial relative density DO. Hence, these results 
suggest that DI values provide a measure of the 
packed initial relative density of the formulations 
on application of small pressure or tapping in 
contrast to that of DO, which provide a measure 
of loose initial relative density due solely to die 
filling 17. 
 
Table 2. Crushing strength, friability and crushing strength-friability ratio (csfr) for chloroquine 
phosphate tablets at relative density 0.90 
 
Starch Binder 






                         0.0 34.31 ± 2.10 3.83 ± 0.04 8.95  
Trifoliate yam        2.5 73.50 ± 1.22 
 
2.37 ± 0.02 31.01 
 
                              5.0 78.41 ± 1.02 
 
1.33 ± 0.03 58.95 
 
                              7.5 83.33 ± 2.13 
 
0.83 ± 0.02 100.36 
 
                           10.0 88.21 ± 1.03 
 
0.63 ± 0.03 140.00 
 
Corn Starch          2.5 53.92 ± 1.21 
 
2.41 ± 0.06 22.37 
 
 5.0                          56.41 ± 2.01 
 
1.40 ± 0.02 40.29 
 
 7.5                          58.82 ± 2.14 
 
0.96 ± 0.05 61.25 
 
 10.0                        44.10 ± 1.17 
 
0.78 ± 0.02 56.54 
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 Values of Pk, which are an inverse 
measure of the amount of plastic deformation 
occurring during the compression process 17, 
also decreased with starch concentration. 
Formulations containing Trofoliate yam starch 
had lower values than those containing corn 
starch. This implies that formulations containing 
corn starch exhibited a lower degree of total 
plastic deformation during the compression 
process. Hence, it would appear that 
formulations containing trifoliate yam starch 
exhibited a faster onset of plastic deformation 
during compression as indicated by the low Py 
values, and also exhibited a higher degree of 
plastic deformation during the compression 
process.  
 There were no clear cut patterns to the 
variation of the values of DO, DB and DA with 
binder concentration. However, the values of DO 
(packing during die filling) for formulations 
containing yam starch were significantly 
(P<0.001) higher than for those containing corn 
starch. While, the values of DB (densification at 
low pressures) for formulations containing corn 
starch were significantly (P<0.001) higher than 
those of formulations containing yam starch. In 
addition, the total degree of packing (DA) 
achieved was significantly (P<0.05) higher form 
formulations containing corn starch. Thus, 
formulations containing corn starch exhibited 
more packing of particles before a coherent 
tablet was formed during compression. 
The mechanical properties of the tablet 
formulations were assessed by the crushing 
strength and friability of the tablets. While 
crushing strength indicates the strength of the 
tablet, friability values provide a measure of 
tablet weakness. Table 2 presents values of 
crushing strength and friability for all 
formulations at a relative density of 0.90, which 
is representative of commercial tablets.  There 
was increase in crushing strength with 
corresponding decrease in friability values with 
binder concentration for all formulations. It has 
been established that the presence of high 
concentration of plasto-elastic binding agent 
leads to an increase in plastic deformation of the 
formulation and consequently to the formation of 
more solid bonds with increase in tablet strength 
and resistance to fracture and abrasion. 
Formulations containing the experimental starch 
had higher crushing strength values which could 
be due to the lower Pk values which indicate 
greater total plastic deformation during 
compression.  
 The crushing strength-friability ratio 
(CSFR) also provides a parameter for measuring 
tablet strength 17. Generally, the higher the 
CSFR value, the stronger the tablet. The CSFR 
values for all formulations are included in Table 
2. An increase was observed for the tablets with 
increase in binder concentration, with tablets 
containing trifoliate yam starch showing 
significantly (p<0.05) higher values than tablets 
containing corn starch. 
 The disintegration time values for the 
tablets at relative density of 0.90 are presented 
in Table 3. An increase was observed in 
disintegration time with increase in binder 
concentration for all formulations, although there 
 
Table 3. Disintegration and dissolution characteristics of chloroquine phosphate tablets  












                         0.0 3.83 ± 1.01 38.25 ± 0.95 34.14 ± 1.05 0.044 ± 0.012 0.134 ± 0.031 
Trifoliate yam         2.5 5.03 ± 0.22 44.12 ± 1.25 31.25 ± 0.24 0.054 ± 0.001 0.237 ± 0.021 
                              5.0 7.02 ± 0.15 46.28 ± 0.85 33.62 ± 0.15 0.052 ± 0.014 0.126 ±0.014 
                              7.5 8.53 ± 1.02 58.03± 3.21 41.66 ± 0.13 0.041 ± 0.003 0.085 ± 0.002 
                           10.0 9.04 ± 0.16 61.52± 2.47 46.72 ± 0.52 0.029 ± 0.008 0.063 ± 0.120 
Corn Starch           2.5 5.01 ± 0.14 40.14± 0.27 29.42 ± 0.14 0.036 ± 0.001 0.123 ± 0.005 
 5.0                6.55 ± 0.75 42.18 ± 1.19 31.86 ± 0.75 0.033 ± 0.003 0.103 ± 0.001 
 7.5                7.02 ± 0.45 45.63± 2.02 36.07 ± 0.98  0.029 ± 0.015 0.062 ± 0.210 
 10.0              9.51 ± 0.18 47.86± 1.14 38.22 ± 0.17 0.018 ± 0.001 0.059 ± 0.004 
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were no significant (p>0.05) differences in 
disintegration time between the formulations. 
However, all tablets passed the British 
Pharmacopoeia specifications for disintegration 
of uncoated tablets within 15minutes. 
 Fig. 3 shows representative plots of the 
amount of chloroquine phosphate released 
against time for tablets containing 5% w/w 
binder. The values of t80 (time taken for 80% of 
the drug to be released) were calculated. These 
values for all formulations at a relative density of 
0.90 are presented in Table 3. The t80 values 
increased with binder concentration for all tablets 
with trifoliate yam starch formulations showing 
higher values than those containing corn starch. 
 The data obtained was further subjected 
to Kitazawa et al. 18 analysis which involves the 
integrated form of the Noyes-Whitney equation 19 
written as  













Fig 1.: Heckel plots for chloroquine phosphate tablets containing 
5%w/w starch as  binder
Corn starch
Trifolate yam starch












Fig. 2:  Kawakita plots for chloroquine phosphate 























Figure 3: Dissolution plot for chloroquine phosphate 
released vs. time for tablets containing 5%w/w binder
Corn starch
Trifolate yam starch

















Figure 4: ln [Cs/(Cs-c)] vs. time for chloroquine phophate tablets 
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−ln          (7)  
where Cs is the concentration of the 
solute at saturation, C is the concentration at 
time t, and k is dissolution rate constant. Values 
of In [Cs/(Cs-C)] were plotted versus t and shown 
for tablets containing 5% w/w of binder in Figure 
4.  
The Kitazawa plots generally showed 
two straight regression lines of slopes K1 and K2.  
The time at which the lines intersect is denoted 
t1.  Values of k1, k2 and t1 for all samples at 
relative density, D of 0.90 are presented in Table 
3.  The Table shows k1 to be lower than k2 
implying that the dissolution rate of the drug was 
faster after t1. It would appear that changes in 
surface area of the dissolving particles brought 
about by the disintegration and de-aggregation 
of the tablets were manifested in the substantial 
increase in dissolution rate after t1. Values of t1, 
k1 and k2 for formulations containing trifoliate 
yam starch were higher than those for 




The results of the present study show 
that trifoliate yam starch as a binder in 
chloroquine phosphate tablets provides faster 
onset and higher amount of total plastic 
deformation under compression pressure than 
corn starch. Trifoliate yam starch also produced 
tablets with stronger mechanical properties and 
longer disintegration and dissolution times than 
corn starch BP.  The results suggest that 
trifoliate yam could be useful as a binding agent 
when a requirement of high mechanical strength 
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